Management ChangeApr 10, 2026, 05:01 PM
Pelthos Therapeutics Appoints John M. Gay as CFO
AI Summary
Pelthos Therapeutics Inc. announced the appointment of John M. Gay as its new Chief Financial Officer, effective April 10, 2026. Mr. Gay, who previously served as the company's Senior Vice President, Finance & Accounting since 2025, succeeds Francis Knuettel II. He brings over 25 years of public company finance and accounting experience to the role.
Key Highlights
- John M. Gay appointed Chief Financial Officer effective April 10, 2026.
- Mr. Gay succeeds Francis Knuettel II, who served since July 2025.
- Mr. Gay previously served as Senior Vice President, Finance & Accounting since 2025.
- He brings over 25 years of public company finance and accounting experience.
Price Impact
More from PTHS